Product NDC: | 0074-4382 |
Proprietary Name: | Nimbex |
Non Proprietary Name: | Cisatracurium besylate |
Active Ingredient(s): | 10 mg/mL & nbsp; Cisatracurium besylate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0074-4382 |
Labeler Name: | Abbott Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020551 |
Marketing Category: | NDA |
Start Marketing Date: | 19951215 |
Package NDC: | 0074-4382-20 |
Package Description: | 20 mL in 1 VIAL, SINGLE-DOSE (0074-4382-20) |
NDC Code | 0074-4382-20 |
Proprietary Name | Nimbex |
Package Description | 20 mL in 1 VIAL, SINGLE-DOSE (0074-4382-20) |
Product NDC | 0074-4382 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cisatracurium besylate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19951215 |
Marketing Category Name | NDA |
Labeler Name | Abbott Laboratories |
Substance Name | CISATRACURIUM BESYLATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |